Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione

CONTEXT: Polycystic ovary syndrome (PCOS) is a triad of anovulation, insulin resistance, and hyperandrogenism. Androgen excess may correlate with metabolic risk and PCOS consensus criteria define androgen excess on the basis of serum T. Here we studied the utility of the androgen precursor serum and...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Reilly, Michael W., Taylor, Angela E., Crabtree, Nicola J., Hughes, Beverly A., Capper, Farfia, Crowley, Rachel K., Stewart, Paul M., Tomlinson, Jeremy W., Arlt, Wiebke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2014
Materias:
Endocrine Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955250/
https://www.ncbi.nlm.nih.gov/pubmed/24423344
http://dx.doi.org/10.1210/jc.2013-3399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955250/
https://www.ncbi.nlm.nih.gov/pubmed/24423344
http://dx.doi.org/10.1210/jc.2013-3399

Ejemplares similares